Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effect of Prewarming Duration on Blood Flow After Colon Resection Surgery

30. september 2026 oppdatert av: Çiğdem Ünal Kantekin

Evaluation of the Effect of Preoperative Prewarming Duration on Postoperative Perfusion Index in Patients Undergoing Colon Resection Surgery: A Randomized Controlled Trial

This study will examine whether warming patients before colon resection surgery improves blood flow in the fingers during early recovery from general anesthesia. It will also compare two warming durations. A total of 108 adults scheduled for elective colon resection surgery at Kayseri City Hospital will be assigned by chance to one of three groups: 10 minutes of warming before anesthesia, 30 minutes of warming before anesthesia, or no active warming before anesthesia. All three groups will receive warming during surgery as part of routine care.

Warming will be provided using a forced-air warming system. After surgery, a sensor placed on a finger will measure the perfusion index, a noninvasive indicator of blood flow, on arrival in the recovery unit and 5 and 10 minutes later. The main comparison will use the average of these three measurements. The researchers will also assess other circulation measurements, routine blood gas and lactate results, shivering, pain, the time until oral feeding begins, and wound infection during the 14 days after surgery.

Studieoversikt

Status

Har ikke rekruttert ennå

Detaljert beskrivelse

This prospective, single-center, randomized controlled study will be conducted by the Department of Anesthesiology and Reanimation at Kayseri City Hospital. Adults undergoing elective colon resection under general anesthesia will be randomized in a 1:1:1 ratio using a computer-generated randomization list. Allocation will be concealed in sequentially numbered, sealed opaque envelopes opened before the preoperative intervention. The planned sample size is 108 participants, with 36 participants per group.

Active prewarming will be applied in the preoperative preparation area using a forced-air warming system covering the upper and lower body. Device settings will follow manufacturer recommendations and institutional clinical standards. The two prewarming groups will receive 10 or 30 minutes of active warming before anesthesia. The control group will receive routine preoperative care without active prewarming. All groups will receive intraoperative warming and standard anesthesia monitoring and management.

Perfusion index and pleth variability index will be measured noninvasively using a pulse oximeter at postanesthesia care unit (PACU) admission and at 5 and 10 minutes. The primary analysis will compare the arithmetic mean of the three postoperative perfusion index measurements between groups. Arterial blood gas and lactate results will be obtained from routine clinical testing without an additional invasive procedure for research. Demographic characteristics, ASA physical status, anesthesia and surgical duration, perioperative temperature, and relevant intraoperative clinical variables will be recorded.

The primary outcome will be compared using one-way analysis of variance when distributional assumptions are met, or the Kruskal-Wallis test otherwise, with appropriate post-hoc comparisons. Repeated perfusion index measurements will also be examined for group and time effects. Secondary continuous and categorical outcomes will be analyzed with methods appropriate to their distributions. Associations of perfusion index with lactate, blood gas parameters, and pain scores will be examined using Pearson or Spearman correlation. Statistical significance will be set at p < 0.05.

The outcome assessor will be blinded to group assignment. Postoperative pain will be assessed using a 0-10 visual analogue scale at PACU admission and at 5 and 10 minutes. Wound infection will be assessed during the 14-day period following surgery.

Studietype

Intervensjonell

Registrering (Antatt)

108

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Çiğdem Ünal Kantekin, MD
  • Telefonnummer: +90 505 443 3056
  • E-post: drcgdm@hotmail.com

Studiesteder

      • Kayseri, Tyrkia (Türkiye), 38080
        • Kayseri City Hospital
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Age 18 years or older.
  • Scheduled for elective colon resection surgery under general anesthesia.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Willing to participate and able to provide written informed consent.

Exclusion Criteria:

  • Age younger than 18 years.
  • Emergency surgery.
  • Severe vascular disease that may affect peripheral circulation, such as advanced peripheral arterial disease.
  • Severe cardiovascular instability.
  • Fever (>38 degrees Celsius) or hypothermia (<36 degrees Celsius) before surgery.
  • Severe anemia (hemoglobin <8 g/dL).
  • Requirement for vasopressor or inotropic support.
  • A condition in the measurement limb that prevents perfusion index measurement, such as severe peripheral edema, an intravenous line, or involvement of the surgical field.
  • Refusal to participate.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: 10-Minute Prewarming

Participants receive 10 minutes of active forced-air warming in the preoperative preparation area before induction of general anesthesia. Warming covers the upper and lower body, with settings following manufacturer recommendations and institutional standards. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Active warming using a forced-air warming system in the preoperative preparation area before general anesthesia. The upper and lower body are warmed for 10 or 30 minutes according to randomized group assignment. Device temperature settings follow manufacturer recommendations and institutional clinical standards.

Eksperimentell: 30-Minute Prewarming

Participants receive 30 minutes of active forced-air warming in the preoperative preparation area before induction of general anesthesia. Warming covers the upper and lower body, with settings following manufacturer recommendations and institutional standards. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Active warming using a forced-air warming system in the preoperative preparation area before general anesthesia. The upper and lower body are warmed for 10 or 30 minutes according to randomized group assignment. Device temperature settings follow manufacturer recommendations and institutional clinical standards.

Ingen inngripen: Control: No Prewarming

Participants receive routine preoperative care without active prewarming before induction of general anesthesia. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Mean Postoperative Perfusion Index
Tidsramme: At PACU admission and 5 and 10 minutes after admission

Perfusion index (PI) is measured noninvasively using a pulse oximeter at postanesthesia care unit (PACU) admission, 5 minutes, and 10 minutes. The primary outcome is the arithmetic mean of these three measurements. PI reflects the ratio of the pulsatile to nonpulsatile component of the photoplethysmographic signal and is used as an indicator of peripheral perfusion.

At PACU admission and 5 and 10 minutes after admission

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Postoperative Pleth Variability Index
Tidsramme: At PACU admission and 5 and 10 minutes after admission

Pleth variability index (PVI) is measured noninvasively using a pulse oximeter at PACU admission, 5 minutes, and 10 minutes to compare early postoperative changes among the three study groups.

At PACU admission and 5 and 10 minutes after admission
Postoperative Arterial Lactate
Tidsramme: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial lactate concentration, reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission. No additional arterial sampling is performed solely for this study.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial pH
Tidsramme: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial pH obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Carbon Dioxide Partial Pressure
Tidsramme: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial carbon dioxide partial pressure (PaCO2), reported in mmHg, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Oxygen Partial Pressure
Tidsramme: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial oxygen partial pressure (PaO2), reported in mmHg, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Bicarbonate
Tidsramme: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial bicarbonate concentration (HCO3), reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Base Excess
Tidsramme: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial base excess (BE), reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Hemoglobin
Tidsramme: At postanesthesia care unit (PACU) admission (0 minutes)

Hemoglobin concentration, reported in g/dL, recorded from routine blood gas testing at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Shivering
Tidsramme: From PACU admission through the first 30 minutes after admission

Number of participants with postoperative shivering. Shivering is recorded as present or absent during the first 30 minutes after postanesthesia care unit (PACU) admission.

From PACU admission through the first 30 minutes after admission
Time to Initiation of Oral Feeding
Tidsramme: From the end of surgery until initiation of oral feeding, assessed up to 14 days after surgery

Time from the end of surgery to the first initiation of oral feeding, recorded in hours. Participants are followed for initiation of oral feeding for up to 14 days after surgery.

From the end of surgery until initiation of oral feeding, assessed up to 14 days after surgery
Postoperative Pain Score
Tidsramme: At PACU admission and 5 and 10 minutes after admission

Pain intensity assessed using a visual analogue scale (VAS) from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Scores are recorded at PACU admission, 5 minutes, and 10 minutes. Higher scores indicate greater pain.

At PACU admission and 5 and 10 minutes after admission
Wound Infection Within 14 Days After Surgery
Tidsramme: Within 14 days after surgery

Number of participants who develop a wound infection during the 14-day period following surgery. Wound infection is recorded as present or absent.

Within 14 days after surgery

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Çiğdem Ünal Kantekin, MD, Kayseri City Hospital

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

15. oktober 2026

Primær fullføring (Antatt)

15. februar 2027

Studiet fullført (Antatt)

15. mars 2027

Datoer for studieregistrering

Først innsendt

23. september 2026

Først innsendt som oppfylte QC-kriteriene

30. september 2026

Først lagt ut (Faktiske)

5. oktober 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

5. oktober 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

30. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • KCH-PREWARM-2026-1080

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

De-identified individual participant data collected in this study will be made available to other researchers upon reasonable request to the principal investigator.

IPD-delingstidsramme

De-identified individual participant data will be available upon reasonable request beginning with publication of the primary results and continuing for 3 years after publication.

Tilgangskriterier for IPD-deling

Researchers may request de-identified participant-level data by contacting the principal investigator, Çiğdem Ünal Kantekin, at drcgdm@hotmail.com. Requests will be considered on a reasonable-request basis.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere